Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070
What this trial is testing

A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma
Ono Pharmaceutical Co., Ltd. 600
Early research (Phase 1)Active Not RecruitingNCT02496273
What this trial is testing

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Who this might be right for
Gastric Cancer
The First People's Hospital of Changzhou 60
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Not applicableStudy completedNCT05965466
What this trial is testing

The Incidence of Gallstones After Gastrectomy

Who this might be right for
GallstoneGastric Cancer
Hepatopancreatobiliary Surgery Institute of Gansu Province 531
Not applicableUnknownNCT04385641
What this trial is testing

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

Who this might be right for
Advanced Gastric CancerGastroesophageal Cancer
Shandong Golden Brick Biotechnology Co., Ltd. 18
Not applicableStudy completedNCT01325883
What this trial is testing

The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity

Who this might be right for
Tumor of Esophagus, Stomach and Duodenum
Liverpool University Hospitals NHS Foundation Trust 253
Testing effectiveness (Phase 2)UnknownNCT04777162
What this trial is testing

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

Who this might be right for
Gastric CancerColo-rectal Cancer
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT00087503
What this trial is testing

Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy

Who this might be right for
Stomach Neoplasms
Pfizer 28
Large-scale testing (Phase 3)Active Not RecruitingNCT00569127
What this trial is testing

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Who this might be right for
Colorectal Neuroendocrine Tumor G1Gastric Neuroendocrine Tumor G1Neuroendocrine Neoplasm+2 more
National Cancer Institute (NCI) 427
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655661
What this trial is testing

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Ming Liu 52
Testing effectiveness (Phase 2)Study completedNCT04768686
What this trial is testing

FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hanmi Pharmaceutical Company Limited 20
Testing effectiveness (Phase 2)Study completedNCT00382720
What this trial is testing

Docetaxel and Oxaliplatin in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Sanofi 275
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Testing effectiveness (Phase 2)UnknownNCT02596256
What this trial is testing

Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01100801
What this trial is testing

Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Who this might be right for
Recurrent Gastric Cancer
National University Hospital, Singapore 90
Testing effectiveness (Phase 2)UnknownNCT04826107
What this trial is testing

Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 196
Testing effectiveness (Phase 2)Study completedNCT00447330
What this trial is testing

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis
Duke University 60
Not applicableUnknownNCT03228095
What this trial is testing

Volatiles in Breath and Headspace Analysis - Diagnostic Markers

Who this might be right for
TuberculosisGastric CancerPeptic Ulcer+13 more
University of Latvia 3,000
Large-scale testing (Phase 3)Study completedNCT03350477
What this trial is testing

Bioinformation Therapy for Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Fuda Cancer Hospital, Guangzhou 120
Next Page